Reumatología y Enfermedades Inmuno-mediadas ‘IRIDIS’

Artículos Científicos

• Blanco FJ, Silva-Díaz M, Quevedo Vila V, Seoane-Mato D, Pérez Ruiz F, Juan-Mas A, Pego-Reigosa JM, Narváez J, Quilis N, Cortés R, Romero Pérez A, Fábregas Canales D, Font Gayá T, Bordoy Ferrer C, Sánchez-Piedra C, Díaz-González F, Bustabad-Reyes S, en representación del Grupo de Trabajo del Proyecto EPISER2016. Prevalence of symptomatic osteoarthritis in Spain: EPISER2016 study. Reumatol Clin. 2020 Apr;(E-PUB) PMID: 32360025. DOI: 10.1016/j.reuma.2020.01.008. +Pubmed +DOI
• Calvo-Alén J, Vela P, Bustabad S, Maceiras F, Carmona L, Cea-Calvo L. Satisfaction, fulfillment of expectations and adherence to subcutaneous biological drugs in patients with rheumatoid arthritis: ARCO study. Reumatol Clin. 2020 Mar;16(2 Pt 1):116–9. PMID: 29776887. DOI: 10.1016/j.reuma.2018.02.015. +Pubmed +DOI
• Carvalheiro T, Garcia S, Pascoal Ramos MI, Giovannone B, Radstake TRDJ, Marut W, Meyaard L. Leukocyte Associated Immunoglobulin Like Receptor 1 Regulation and Function on Monocytes and Dendritic Cells During Inflammation. Front Immunol. 2020;11(August):1–13. PMID: 32973751. DOI: 10.3389/fimmu.2020.01793. +Pubmed +DOI
• Carvalheiro T, Lopes AP, van der Kroef M, Malvar-Fernandez B, Rafael-Vidal C, Hinrichs AC, Servaas NH, Bonte-Mineur F, Kok MR, Beretta L, Zimmermann M, Marut W, Pego-Reigosa JM, Radstake TRDJ, García S. Angiopoietin-2 Promotes Inflammatory Activation in Monocytes of Systemic Sclerosis Patients. Int J Mol Sci. 2020;21((24)):9544. DOI: 10.3390/ijms21249544. +DOI
• Carvalheiro T, Malvar Fernández B, Ottria A, Giovannone B, Marut W, Reedquist KA, Garcia S, Radstake TR. Extracellular SPARC cooperates with TGF-? signalling to induce pro-fibrotic activation of systemic sclerosis patient dermal fibroblasts. Rheumatol (United Kingdom). 2020;59(9):2258–63. PMID: 31840182. DOI: 10.1093/rheumatology/kez583. +Pubmed +DOI
• Carvalheiro T, Rafael-Vidal C, Malvar-Fernandez B, Lopes AP, Pego-Reigosa JM, Radstake TRDJ, Garcia S. Semaphorin4a-plexin d1 axis induces th2 and th17 while represses th1 skewing in an autocrine manner. Int J Mol Sci. 2020;21(18):1–11. PMID: 32971928. DOI: 10.3390/ijms21186965. +Pubmed +DOI
• Cobo-Ibáñez T, Urruticoechea-Arana A, Rúa-Figueroa I, Martín-Martínez MA, Ovalles-Bonilla JG, Galindo M, Calvo-Alén J, Olivé A, Fernández-Nebro A, Menor-Almagro R, Tomero E, Horcada L, Uriarte-Itzazelaia E, Martínez-Taboada VM, Andreu JL, Boteanu A, Narváez J, Bohorquez C, Montilla C, Santos G, Hernández-Cruz B, Vela P, Salgado E, Freire M, Hernández-Beriain JÁ, Díez-Álvarez E, Expósito L, Fernández-Berrizbeitia O, Velloso-Feijoo ML, Ibáñez-Barceló M, Lozano-Rivas N, Bonilla G, Moreno M, Raya E, Quevedo-Vila VE, Vázquez-Rodríguez TR, Ibáñez-Ruan J, Muñoz-Fernández S, Sánchez-Alonso F, Pego-Reigosa JM. Hormonal Dependence and Cancer in Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2020 Feb;72(2):216–24. PMID: 31529686. DOI: 10.1002/acr.24068. +Pubmed +DOI
• Cortés Verdú R, Pego-Reigosa JM, Seoane-Mato D, Morcillo Valle M, Palma Sánchez D, Moreno Martínez MJ, Mayor González M, Atxotegi Sáenz de Buruaga J, Urionagüena Onaindia I, Blanco Cáceres BA, Silva-Fernández L, Sivera F, Blanco FJ, Sánchez-Piedra C, Díaz-González F, Bustabad S, Working Group Proyecto EPISER2016. Prevalence of systemic lupus erythematosus in Spain: higher than previously reported in other countries? Rheumatology (Oxford). 2020 Sep;59(9):2556–62. PMID: 31998955. DOI: 10.1093/rheumatology/kez668. +Pubmed +DOI
• Gómez-Vaquero C, Fábregas-Canales D, Seoane-Mato D, Sánchez-Piedra C, Díaz-González F, Bustabad-Reyes S, Silva-Fernández L, Sivera F, Quilis Martí N, Blanco FJ, Pérez Ruiz F, Atxotegi Sáenz de Buruaga J, Urionagüena Onaindia I, Blanco Cáceres BA, Juan-Mas A, Pego-Reigosa JM, Narváez J, Cortés Verdú R, Antón-Pagés F, Quevedo Vila V, Garrido Courel L, del Val del Amo N, Paniagua Zudaire I, Añez Sturchio G, Medina Varo F, Gandía Martínez M, Romero Pérez A, Ballina J, Brandy García A, Fábregas Canales D, Font Gayá T, Bordoy Ferrer C, González Álvarez B, Casas Hernández L, Álvarez Reyes F, Delgado Sánchez M, Martínez Dubois C, Sánchez-Fernández SÁ, Rojas Vargas LM, García Morales PV, Olivé A, Rubio Muñoz P, Larrosa M, Navarro Ricos N, Graell Martín E, Chamizo E, Chaves Chaparro L, Rojas Herrera S, Pons Dolset J, Polo Ostariz MÁ, Ruiz-Alejos Garrido S, Macía Villa C, Cruz Valenciano A, González Gómez ML, Morcillo Valle M, Palma Sánchez D, Moreno Martínez MJ, Mayor González M. Valoración del riesgo de fractura en po +Pubmed +DOI
• Hernández Cruz B, Alonso F, Calvo Alén J, Pego-Reigosa JM, López-Longo FJ, Galindo-Izquierdo M, Olivé A, Tomero E, Horcada L, Uriarte E, Erausquin C, Sánchez-Atrio A, Montilla C, Santos Soler G, Fernández-Nebro A, Blanco R, Rodríguez-Gómez M, Vela P, Freire M, Díez-Álvarez E, Boteanu AL, Narváez J, Martínez Taboada V, Ruiz-Lucea E, Andreu JL, Fernández-Berrizbeitia O, Hernández-Beriain JÁ, Gantes M, Pérez-Venegas JJ, Ibáñez-Barceló M, Pecondón-Español Á, Marras C, Bonilla G, Castellví I, Moreno M, Raya E, Quevedo Vila VE, Vázquez T, Ruán JI, Muñoz S, Rúa-Figueroa Í, RELESSER (Spanish Society of Rheumatology Systemic Lupus Erythematosus register) group. Differences in clinical manifestations and increased severity of systemic lupus erythematosus between two groups of Hispanics: European Caucasians versus Latin American mestizos (data from the RELESSER registry). Lupus. 2020 Jan;29(1):27–36. PMID: 31801040. DOI: 10.1177/0961203319889667. +Pubmed +DOI
• Johnson SR, Brinks R, Costenbader KH, Daikh D, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, Jayne D, Cervera R, Costedoat-Chalumeau N, Diamond B, Gladman DD, Hahn B, Hiepe F, Jacobsen S, Khanna D, Lerstrøm K, Massarotti E, McCune J, Ruiz-Irastorza G, Sanchez-Guerrero J, Schneider M, Urowitz M, Bertsias G, Hoyer BF, Leuchten N, Tani C, Tedeschi SK, Touma Z, Schmajuk G, Anic B, Assan F, Chan TM, Clarke AE, Crow MK, Czirják L, Doria A, Graninger WB, Halda-Kiss B, Hasni S, Izmirly PM, Jung M, Kumánovics G, Mariette X, Padjen I, Pego-Reigosa JM, Romero-Diaz J, Rúa-Figueroa Í, Seror R, Stummvoll GH, Tanaka Y, Tektonidou MG, Vasconcelos C, Vital EM, Wallace DJ, Yavuz S, Meroni PL, Fritzler MJ, Naden R, Dörner T, Aringer M. Performance of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicities. Ann Rheum Dis. 2020 Oct;79(10):1333–9. PMID: 32816709. DOI: 10.1136/annrheumdis-2020-217162. +Pubmed +DOI
• Kabala PA, Malvar-Fernández B, Lopes AP, Carvalheiro T, Hartgring SAY, Tang MW, Conde C, Baeten DL, Sleeman M, Tak PP, Connor J, Radstake TR, Reedquist KA, García S. Promotion of macrophage activation by Tie2 in the context of the inflamed synovia of rheumatoid arthritis and psoriatic arthritis patients. Rheumatol (United Kingdom). 2020;59(2):426–38. PMID: 31377797. DOI: 10.1093/rheumatology/kez315. +Pubmed +DOI
• Martinez-Lopez-de-Castro N, Alvarez-Payero M, Samartin-Ucha M, Martin-Vila A, Pineiro-Corrales G, Rodriguez-Rodriguez M, Maceiras-Pan FJ, Melero-Gonzalez RB, Pego-Reigosa JM. Biological therapy safety in chronic inflammatory arthropathy patients. Eur J Rheumatol. 2020 May;7(2):53–9. PMID: 32644925. DOI: 10.5152/eurjrheum.2019.19123. +Pubmed +DOI
• Martínez-López-de-Castro N, Álvarez-Payero M, Samartín-Ucha M, Martínez-Reglero C, Martín-Vila A, Rodríguez-Rodríguez M, Piñeiro-Corrales G, Maceiras-Pan FJ, Melero-González RB, Pego-Reigosa JM. Direct costs in patients with chronic inflammatory arthropathies on biological therapy: a real-world data study. Clin Exp Rheumatol. 2020;(E-PUB) PMID: 32896255. +Pubmed
• Mena-Vázquez N, Fernández-Nebro A, Pego-Reigosa JM, Galindo M, Melissa-Anzola A, Uriarte-Isacelay E, Olivé-Marqués A, Aurrecoechea E, Freire M, Tomero E, García-Villanueva MJ, Stoye C, Salas-Heredia E, Bernal-Vidal JA, Salgado E, Blanco R, Javier Novoa F, Ibáñez-Barcelo M, Torrente-Segarra V, Narvaez J, Calvet J, Moriano Morales C, Ramon Vazquez-Rodriguez T, Garcia de la Peña P, Bohórquez C, Andreu-Sánchez JL, Cobo-Ibañez T, Bonilla G, Lozano-Rivas N, Montilla C, Toyos FJ, De la Fuente JLM, Expósito L, Ruiz-Lucea ME, Vals E, Manero-Ruiz J, Bernal-Vidal JA, Rua-Figueroa I. Hydroxychloroquine is associated with a lower risk of polyautoimmunity: data from the RELESSER Registry. Rheumatology. 2020 Aug;59(8):2043–51. PMID: 31808534. DOI: 10.1093/rheumatology/kez562. +Pubmed +DOI
• Morand EF, Furie R, Tanaka Y, Bruce IN, Askanase AD, Richez C, Bae S-C, Brohawn PZ, Pineda L, Berglind A, Tummala R, TULIP-2 Trial Investigators. Trial of Anifrolumab in Active Systemic Lupus Erythematosus. N Engl J Med. 2020 Jan;382(3):211–21. PMID: 31851795. DOI: 10.1056/NEJMoa1912196. +Pubmed +DOI
• Pego-Reigosa JM, Nicholson L, Pooley N, Langham S, Embleton N, Marjenberg Z, Barut V, Desta B, Wang X, Langham J, Hammond ER. The risk of infections in adult patients with systemic lupus erythematosus: systematic review and meta-analysis. Rheumatology. 2020 Oct;(E-PUB) PMID: 33099651. DOI: 10.1093/rheumatology/keaa478. +Pubmed +DOI
• Queiro R, Coto P, Joven B, Rivera R, Navío Marco T, de la Cueva P, Alvarez Vega JL, Narváez Moreno B, Rodriguez Martínez FJ, Pardo Sánchez J, Feced Olmos C, Pujol C, Rodríguez J, Notario J, Pujol Busquets M, García Font M, Galindez E, Pérez Barrio S, Urruticoechea-Arana A, Hergueta M, López Montilla MD, Vélez García-Nieto A, Maceiras F, Rodríguez Pazos L, Rubio Romero E, Rodríguez Fernandez Freire L, Luelmo J, Gratacós J. Current status of multidisciplinary care in psoriatic arthritis in Spain: NEXUS 2.0 project. Reumatol Clin. 2020 Feb;16(1):24–31. PMID: 29496420. DOI: 10.1016/j.reuma.2018.01.010. +Pubmed +DOI
• Rafael-Vidal C, Pérez N, Altabás I, Garcia S, Pego-Reigosa JM. Blocking il-17: A promising strategy in the treatment of systemic rheumatic diseases. Int J Mol Sci. 2020;21(19):1–14. PMID: 32993066. DOI: 10.3390/ijms21197100. +Pubmed +DOI
• Riancho-Zarrabeitia L, Martínez-Taboada V, Rúa-Figueroa I, Alonso F, Galindo-Izquierdo M, Ovalles J, Olivé-Marqués A, Fernández-Nebro A, Calvo-Alén J, Menor-Almagro R, Tomero-Muriel E, Uriarte-Isacelaya E, Botenau A, Andres M, Freire-González M, Santos Soler G, Ruiz-Lucea E, Ibáñez-Barceló M, Castellví I, Galisteo C, Quevedo Vila V, Raya E, Narváez-García J, Expósito L, Hernández-Beriaín JA, Horcada L, Aurrecoechea E, Pego-Reigosa JM. Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more damage accrual and higher mortality. Lupus. 2020 Oct;29(12):1556–65. PMID: 32807021. DOI: 10.1177/0961203320950477. +Pubmed +DOI
• Riancho-Zarrabeitia L, Martínez-Taboada VM, Rúa-Figueroa I, Alonso F, Galindo-Izquierdo M, Ovalles J, Olivé-Marqués A, Mena-Vázquez N, Calvo-Alén J, Menor-Almagro R, Tomero-Muriel E, Uriarte-Isacelaya E, Boteanu A, Andres M, González MF, Soler GS, Ruiz-Lucea ME, Ibáñez-Barceló M, Castellví I, Galisteo C, Quevedo-Vila V, Raya E, Narváez J, Expósito L, Hernández-Beriaín JA, Horcada L, Aurrecoechea E, Pego-Reigosa JM. Do all antiphospholipid antibodies confer the same risk for major organ involvement in systemic lupus erythematosus patients? Clin Exp Rheumatol. 2020;(E-PUB) PMID: 32828148. +Pubmed
• Riveros Frutos A, Holgado S, Sanvisens Bergé A, Casas I, Olivé A, López-Longo FJ, Calvo-Alén J, Galindo M, Fernández-Nebro A, Pego-Reigosa JM, Rúa-Figueroa I, RELESSER Group. Late-onset versus early-onset systemic lupus: characteristics and outcome in a national multicentre register (RELESSER). Rheumatology (Oxford). 2020 Oct;(E-PUB) PMID: 33106841. DOI: 10.1093/rheumatology/keaa477. +Pubmed +DOI
• Rúa-Figueroa Fernández de Larrinoa I, Pego-Reigosa JM, en representación de los investigadores del proyecto RELESSER y del grupo EAS-SER, Investigadores del registro RELESSER en su fase transversal. Contributions of the lupus register of the Spanish Society of Rheumatology (RELESSER) to the knowledge of systemic lupus erythematosus in Spain. Reumatol Clin. 2020 Mar;(E-PUB) PMID: 32205082. DOI: 10.1016/j.reuma.2020.01.006. +Pubmed +DOI
• Rúa-Figueroa I, López-Longo FJ, Del Campo V, Galindo-Izquierdo M, Uriarte E, Torre-Cisneros J, Vela P, Tomero E, Narváez J, Olivé A, Freire M, Salgado E, Andreu JL, Martínez-Taboada V, Calvo-Alén J, Hernández-Cruz B, Raya E, Quevedo V, Expósito Pérez L, Fernández-Nebro A, Ibañez M, Pascual-Valls È, Rúa-Figueroa D, Naranjo A, Pego-Reigosa JM. Bacteremia in Systemic Lupus Erythematosus in Patients from a Spanish Registry: Risk Factors, Clinical and Microbiological Characteristics, and Outcomes. J Rheumatol. 2020 Feb;47(2):234–40. PMID: 30988123. DOI: 10.3899/jrheum.180882. +Pubmed +DOI
• Salman-Monte TC, Sanchez-Piedra C, Fernandez Castro M, Andreu JL, Martinez Taboada V, Olivé A, Rosas J, Menor R, Rodríguez B, Garcia Aparicio A, Lopez Longo FJ, Manrique-Arija S, Garcia Vadillo JA, Gil Barato S, López-González R, Galisteo C, Gonzalez Martin J, Ruiz Lucea E, Erausquin C, Melchor S, Moreira B, Raya E, Pego-Reigosa JM, Cid N, Júdez E, Moriano C, Narváez FJ, Corominas H, Garcia Magallon B, Guillen Astete C, Castellvi I, Bohórquez C, Loricera J, Belzunegui J, Illera Ó, Torrente-Segarra V. Prevalence and factors associated with osteoporosis and fragility fractures in patients with primary Sjögren syndrome. Rheumatol Int. 2020 Aug;40(8):1259–65. PMID: 32533289. DOI: 10.1007/s00296-020-04615-3. +Pubmed +DOI
• Samartín-Ucha M, Pego-Reigosa JM, Álvarez-Payero M, Martin-Vila A, Pineiro-Corrales G, Rodriguez-Rodriguez M, Melero-Gonzalez RB, Maceiras-Pan F, Martinez-Reglero C, Mrtinez-Lopez de Castro N. Medication persistence on biological therapies prescribed for the treatment of chronic inflammatory arthropathies: a real-world data study. Eur J Hosp Pharm Sci Pract. 2020 May;(E-PUB) PMID: 32404382. DOI: 10.1136/ejhpharm-2019-002133. +Pubmed +DOI
• Sanchez-Piedra C, Diaz-Torne C, Manero J, Pego-Reigosa JM, Rúa-Figueroa Í, Gonzalez-Gay MA, Gomez-Reino J, Alvaro-Gracia JM, BIOBADASER study group. Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies. Ann Rheum Dis. 2020;79(7):988–90. PMID: 32503857. DOI: 10.1136/annrheumdis-2020-217948. +Pubmed +DOI
• Torrente-Segarra V, Salman-Monte TC, Rúa-Figueroa Í, Del Campo V, López-Longo FJ, Galindo-Izquierdo M, Calvo-Alén J, Olivé-Marqués A, Mouriño-Rodríguez C, Horcada L, Bohórquez C, Montilla C, Salgado E, Díez-Álvarez E, Blanco R, Andreu JL, Fernández-Berrizbeitia O, Expósito L, Gantes M, Hernández-Cruz B, Pecondón-Español Á, Lozano-Rivas N, Bonilla G, Lois Iglesias A, Rubio-Muñoz P, Ovalles J, Tomero E, Boteanu A, Narvaez J, Freire M, Vela P, Quevedo-Vila V, Juan Mas A, Muñoz-Fernández S, Raya E, Moreno M, Velloso-Feijoo ML, Soler G, Vázquez-Rodríguez TR, Pego-Reigosa JM, RELESSER Study Group of the Spanish Society of Rheumatology (SER) and the Study Group of Systemic Autoimmune Diseases of the SER (EAS-SER). Associated factors to serious infections in a large cohort of juvenile-onset systemic lupus erythematosus from Lupus Registry (RELESSER). Semin Arthritis Rheum. 2020 May;50(4):657–62. PMID: 32505871. DOI: 10.1016/j.semarthrit.2020.05.016. +Pubmed +DOI
• Urruticoechea-Arana A, León-Vázquez F, Giner-Ruiz V, Andréu-Sánchez JL, Olivé-Marqués A, Freire-González M, Pego-Reigosa JM, Muñoz-Fernández S, Román-Ivorra JA, Alegre-Sancho JJ, Vargas-Negrín F, Medina-Abellán M, Cobo-Ibáñez T, Mas-Garriga X, Calvo-Alén J, Costa-Ribas C, Blanco-Vela R, Pérez-Martín Á, Beltrán-Catalán E, Forcada-Gisbert J, Hernández-Miguel MV, Hermosa-Hernán JC, Narváez-García J, Nieto-Pol E, Rúa-Figueroa Í. Development of an application for mobile phones (App) based on the collaboration between the Spanish Society of Rheumatology and Spanish Society of Family Medicine for the referral of systemic autoimmune diseases from primary care to rheumatology. Reumatol Clin. 2020 Sep;16(5 Pt 2):373–7. PMID: 31722849. DOI: 10.1016/j.reuma.2019.09.001. +Pubmed +DOI
• Wienke J, Mertens JS, Garcia S, Lim J, Wijngaarde CA, Yeo JG, Meyer A, van den Hoogen LL, Tekstra J, Hoogendijk JE, Otten HG, Fritsch-Stork RDE, de Jager W, Seyger MMB, Thurlings RM, de Jong EMGJ, van der Kooi AJ, van der Pol WL, Kamphuis Rotterdam SSM, Hoppenreijs Nijmegen EPAH, van den Berg JM, Hissink Muller PCE, Arkachaisri T, Radstake TRDJ, van Royen-Kerkhof A, van Wijk F. Biomarker profiles of endothelial activation and dysfunction in rare systemic autoimmune diseases: implications for cardiovascular risk. Rheumatology. 2020 Aug;(E-PUB) PMID: 32810267. DOI: 10.1093/rheumatology/keaa270. +Pubmed +DOI

Artículos Científicos

• Altabás-González I, Pérez-Gómez N, Pego-Reigosa JM. How to investigate: Suspected systemic rheumatic diseases in patients presenting with muscle complaints. Best Pract Res Clin Rheumatol. 2019 Aug;33(4):101437. PMID: 31810549. DOI: 10.1016/j.berh.2019.101437. +Pubmed +DOI
• Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, Jayne D, Cervera R, Costedoat-Chalumeau N, Diamond B, Gladman DD, Hahn B, Hiepe F, Jacobsen S, Khanna D, Lerstrøm K, Massarotti E, McCune J, Ruiz-Irastorza G, Sanchez-Guerrero J, Schneider M, Urowitz M, Bertsias G, Hoyer BF, Leuchten N, Tani C, Tedeschi SK, Touma Z, Schmajuk G, Anic B, Assan F, Chan TM, Clarke AE, Crow MK, Czirják L, Doria A, Graninger W, Halda-Kiss B, Hasni S, Izmirly PM, Jung M, Kumánovics G, Mariette X, Padjen I, Pego-Reigosa JM, Romero-Diaz J, Rúa-Figueroa Fernández Í, Seror R, Stummvoll GH, Tanaka Y, Tektonidou MG, Vasconcelos C, Vital EM, Wallace DJ, Yavuz S, Meroni PL, Fritzler MJ, Naden R, Dörner T, Johnson SR. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019 Jun;78(9):1151–9. PMID: 31383717. DOI: 10.1136/annrheumdis-2018-214819. +Pubmed +DOI
• Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey?Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, Jayne D, Cervera R, Costedoat?Chalumeau N, Diamond B, Gladman DD, Hahn B, Hiepe F, Jacobsen S, Khanna D, Lerstrøm K, Massarotti E, McCune J, Ruiz?Irastorza G, Sanchez?Guerrero J, Schneider M, Urowitz M, Bertsias G, Hoyer BF, Leuchten N, Tani C, Tedeschi SK, Touma Z, Schmajuk G, Anic B, Assan F, Chan TM, Clarke AE, Crow MK, Czirják L, Doria A, Graninger W, Halda?Kiss B, Hasni S, Izmirly PM, Jung M, Kumánovics G, Mariette X, Padjen I, Pego?Reigosa JM, Romero?Diaz J, Rúa?Figueroa Fernández Í, Seror R, Stummvoll GH, Tanaka Y, Tektonidou MG, Vasconcelos C, Vital EM, Wallace DJ, Yavuz S, Meroni PL, Fritzler MJ, Naden R, Dörner T, Johnson SR. 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheumatol. 2019 Sep;71(9):1400–12. PMID: 31385462. DOI: 10.1002/art.40930. +Pubmed +DOI
• De Castro NML, Álvarez-Payero M, Samartín-Ucha M, Martín-Vila A, Piñeiro-Corrales G, Pego Reigosa JM, Rodríguez-Rodríguez M, Melero-González RB, Maceiras-Pan FJ. Adherence to biological therapies in patients with chronic inflammatory arthropathies. Farm Hosp. 2019;43(4):134–9. PMID: 31276446. DOI: 10.7399/fh.11183. +Pubmed +DOI
• López V, Castro ML De, Ucha S, Meléndez F. Evaluación de la satisfacción global de los pacientes con nutrición enteral domiciliaria en la consulta de farmacia hospitalaria?: estudio. Rev Nutr Clin y Diet Hosp. 2019;39(3):146–53. DOI: 10.12873/393vazquez. +DOI
• Martínez-López De Castro N, Samartín-Ucha M, Martín-Vila A, Álvarez-Payero M, Piñeiro-Corrales G, Pego-Reigosa JM. Content analysis of Twitter in relation to biological treatments for chronic inflammatory arthropathies: an exploratory study. Eur J Hosp Pharm Sci Pract. 2019 May;26(3):124–8. PMID: 31428318. DOI: 10.1136/ejhpharm-2017-001402. +Pubmed +DOI
• Pego-Reigosa JM, Restrepo Vélez J, Baldini C, Rúa-Figueroa Fernández de Larrinoa Í. Comorbidities (excluding lymphoma) in Sjögren´s syndrome. Rheumatology. 2019 Feb;(E-PUB) PMID: 30770715. DOI: 10.1093/rheumatology/key329. +Pubmed +DOI
• Rosas J, Sánchez-Piedra C, Fernández-Castro M, Andreu JL, Martínez-Taboada V, Olivé A, SJÖGRENSER Group, part of the Spanish Society of Rheumatology Systemic Autoimmune Diseases Study Group-EASSER (Marina Rodríguez López; Coral Mouriño; JMP. ESSDAI activity index of the SJÖGRENSER cohort: analysis and comparison with other European cohorts. Rheumatol Int. 2019 Jun;39(6):991–9. PMID: 30891620. DOI: 10.1007/s00296-019-04285-w. +Pubmed +DOI
• Samartín-Ucha M, Castro-Domínguez J, Fernández-Vega H, Piñeiro-Corrales G, Coordinating Group on Safety in High-Alert-Medication in Xerencia de Xestión Integrada de Vigo VS (Noemí M-L-CAP-C. Devising of a risk map on the management of high risk alert medication in a high level university hospital. Farm Hosp. 2019;43(3):110–5. PMID: 31072289. DOI: 10.7399/fh.11175. +Pubmed +DOI
• Samartín-Ucha M, Piñeiro-Corrales G, Continuity of Care Group from the EOXI Vigo. Model of teleconsultation pharmaceutical integrated in the electronic clinical history of the patient. Farm Hosp. 2019;43(1):1–5. PMID: 30624166. DOI: 10.7399/fh.10937. +Pubmed +DOI
• Seoane-Mato D, Sánchez-Piedra C, Silva-Fernández L, Sivera F, Blanco FJ, Pérez Ruiz F, Juan-Mas A, Pego-Reigosa JM, Narváez J, Quilis Martí N, Cortés Verdú R, Antón-Pagés F, Quevedo Vila V, Garrido Courel L, Del Amo NDV, Paniagua Zudaire I, Añez Sturchio G, Medina Varo F, Ruiz Tudela MDM, Romero Pérez A, Ballina J, Brandy García A, Fábregas Canales D, Font Gayá T, Bordoy Ferrer C, González Álvarez B, Casas Hernández L, Álvarez Reyes F, Delgado Sánchez M, Martínez Dubois C, Sánchez-Fernández SÁ, Rojas Vargas LM, García Morales PV, Olivé A, Rubio Muñoz P, Larrosa M, Navarro Ricos N, Graell Martín E, Chamizo E, Chaves Chaparro L, Rojas Herrera S, Pons Dolset J, Polo Ostariz MÁ, Ruiz-Alejos Garrido S, Macía Villa C, Cruz Valenciano A, González Gómez ML, Morcillo Valle M, Palma Sánchez D, Moreno Martínez MJ, Mayor González M, Atxotegi Sáenz de Buruaga J, Urionagüena Onaindia I, Blanco Cáceres BA, Díaz-González F, Bustabad S. Prevalence of rheumatic diseases in adult population in Spain (EPISER 2016 study): Aims an +Pubmed +DOI
• Silva-Fernández L, Otón T, Askanase A, Carreira P, López-Longo FJ, Olivé A, Rúa-Figueroa Í, Narváez J, Ruiz-Lucea E, Andrés M, Calvo E, Toyos F, Alegre-Sancho JJ, Tomero E, Montilla C, Zea A, Uriarte E, Calvo-Alén J, Marras C, Martínez-Taboada VM, Belmonte-López MÁ, Rosas J, Raya E, Bonilla G, Freire M, Pego-Reigosa JM, Millán I, Hughes-Morley A, Andreu JL, from the Spanish Society for Rheumatology Systemic Autoimmune Diseases Study Group (EAS-SER). Pure Membranous Lupus Nephritis: Description of a Cohort of 150 Patients and Review of the Literature. Reumatol Clin. 2019 May;15(1):34–42. PMID: 28528869. DOI: 10.1016/j.reuma.2017.04.005. +Pubmed +DOI
• Tejera Segura B, Rua-Figueroa I, Pego-Reigosa JM, Del Campo V, Wincup C, Isenberg D, Rahman A. Can we validate a clinical score to predict the risk of severe infection in patients with systemic lupus erythematosus? A longitudinal retrospective study in a British Cohort. BMJ Open. 2019;9(6):1–9. PMID: 31203250. DOI: 10.1136/bmjopen-2018-028697. +Pubmed +DOI
• Torrente-Segarra V, Salman Monte TC, Rúa-Figueroa I, De Uña-Álvarez J, Balboa-Barreiro V, López-Longo FJ, Galindo-Izquierdo M, Calvo-Alén J, Olivé-Marqués A, Mouriño-Rodríguez C, Horcada L, Sánchez-Atrio A, Montilla C, Salgado E, Díez-Álvarez E, Blanco R, Andreu JL, Fernández-Berrizbeitia O, Hernández-Beriain JA, Gantes M, Hernández-Cruz B, Pecondón-Español A, Marras C, Bonilla G, Pego-Reigosa JM, RELESSER Study Group of the Spanish Society of Rheumatology (SER) and the Study Group of Systemic Autoimmune Diseases of the SER (EAS-SER). Relationship between damage and mortality in juvenile-onset systemic lupus erythematosus: Cluster analyses in a large cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER). Semin Arthritis Rheum. 2019 Sep;48(6):1025–9. PMID: 30344081. DOI: 10.1016/j.semarthrit.2018.09.005. +Pubmed +DOI

Artículos Científicos

• Julià A, López-Longo FJ, Pérez Venegas JJ, Bonàs-Guarch S, Olivé À, Andreu JL, Aguirre-Zamorano MÁ, Vela P, Nolla JM, de la Fuente JLM, Zea A, Pego-Reigosa JM, Freire M, Díez E, Rodríguez-Almaraz E, Carreira P, Blanco R, Taboada VM, López-Lasanta M, Corbeto ML, Mercader JM, Torrents D, Absher D, Marsal S, Fernández-Nebro A. Genome-wide association study meta-analysis identifies five new loci for systemic lupus erythematosus. Arthritis Res Ther. 2018 May;20(1):100. PMID: 29848360. DOI: 10.1186/s13075-018-1604-1. +Pubmed +DOI
• Martínez-López de Castro N, Matilla-Fernández MB, Fraga-Fuentes MD, Mangues-Bafalluy I, Asensi-Díez R, Cajaraville-Ordoñana G. Spanish Society of Hospital Pharmacy position paper on biosimilar medicines. Farm Hosp. 2018 Jul;42(4):180–3. PMID: 29959844. DOI: 10.7399/fh.10973. +Pubmed +DOI
• Martínez-López-de-Castro N, Álvarez-Payero M, Martín-Vila A, Samartín-Ucha M, Iglesias-Neiro P, Gayoso-Rey M, Feijoo-Meléndez D, Casanova-Martínez C, Fariña-Conde M, Piñeiro-Corrales G. Factors associated with patient satisfaction in an outpatient hospital pharmacy. Eur J Hosp Pharm. 2018 Jul;25(4):183–8. DOI: 10.1136/ejhpharm-2016-001192. +DOI
• Narváez J, Borrell H, Sánchez-Alonso F, Rúa-Figueroa I, López-Longo FJ, Galindo-Izquierdo M, Calvo-Alén J, Fernández-Nebro A, Olivé A, Andreu JL, Martínez-Taboada V, Nolla JM, Pego-Reigosa JM, RELESSER Study Group. Primary respiratory disease in patients with systemic lupus erythematosus: data from the Spanish rheumatology society lupus registry (RELESSER) cohort. Arthritis Res Ther. 2018;20(1):280. PMID: 30567600. DOI: 10.1186/s13075-018-1776-8. +Pubmed +DOI
• Romero-Ventosa EY, Gayoso-Rey M, Samartín-Ucha M, Lamas-Domínguez P, Rubianes-González M, Rodríguez-Lorenzo D, Rodríguez-Vázquez MH, García-Comesaña J, Piñeiro-Corrales G. Pharmacotherapeutic Reports as Tools for Detecting Discrepancies in Continuity of Care. Ther Innov Regul Sci. 2018 Jan;52(1):94–9. PMID: 29714617. DOI: 10.1177/2168479017716716. +Pubmed +DOI

Artículos Científicos

• Alvarez-Payero M, Valeiras-Muñoz C, Lion-Vázquez S, Piñeiro-Corrales G, Muñoz-García D, Midaglia L. Experience with fampridine in clinical practice: analysis of a possible marker of clinical response. Int J Neurosci. 2017 Oct;127(10):915–22. PMID: 28054826. DOI: 10.1080/00207454.2017.1279614. IF2017: 1.848; Q4. +Pubmed +DOI
• Blanco Pérez JJ, Arnalich Montiel V, Guerra Vales JL. Plastic bronchitis in a patient with silicosis. Arch Bronconeumol. 2017 Sep;53(9):516. PMID: 28365186. DOI: 10.1016/j.arbres.2017.02.012. IF2017: 2.633; Q2. +Pubmed +DOI
• Cabrerizo M, García-Iñiguez JP, Munell F, Amado A, Madurga-Revilla P, Rodrigo C, Pérez S, Martínez-Sapiña A, Antón A, Suárez G, Rabella N, Del Campo V, Otero A, Masa-Calles J. First Cases of Severe Flaccid Paralysis Associated With Enterovirus D68 Infection in Spain, 2015-2016. Pediatr Infect Dis J. 2017 Dec;36(12):1214–6. PMID: 28661963. DOI: 10.1097/INF.0000000000001668. IF2017: 2.305; Q2. +Pubmed +DOI
• Calvo-Alén J, Monteagudo I, Salvador G, Vázquez-Rodríguez TR, Tovar-Beltrán J V, Vela P, Maceiras F, Bustabad S, Román-Ivorra JA, Díaz-Miguel C, Rosas J, Raya E, Carmona L, Cea-Calvo L, Arteaga MJ, Fernández S, Marras C. Non-adherence to subcutaneous biological medication in patients with rheumatoid arthritis: a multicentre, non-interventional study. Clin Exp Rheumatol. 2017 May;35(3):423–30. PMID: 28032846. IF2017: 3.201; Q2. +Pubmed
• Clowse MEB, Wallace DJ, Furie RA, Petri MA, Pike MC, Leszczy?ski P, Neuwelt CM, Hobbs K, Keiserman M, Duca L, Kalunian KC, Galateanu C, Bongardt S, Stach C, Beaudot C, Kilgallen B, Gordon C, EMBODY Investigator Group ( JM Pego-Reigosa). Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials. Arthritis Rheumatol (Hoboken, NJ). 2017 Feb;69(2):362–75. PMID: 27598855. DOI: 10.1002/art.39856. IF2017: 7.871; D1. +Pubmed +DOI
• Cordero OJ, Varela-Calviño R, López-González T, Grujic M, Juranic Z, Mouriño C, Hernández-Rodríguez Í, Rodríguez-López M, de la Iglesia BA, Pego-Reigosa JM. Anti-CD26 autoantibodies are involved in rheumatoid arthritis and show potential clinical interest. Clin Biochem. 2017 Nov;50(16–17):903–10. PMID: 28599787. DOI: 10.1016/j.clinbiochem.2017.06.001. IF2017: 2.584; Q2. +Pubmed +DOI
• de Castro ML, Sanromán L, Martín A, Figueira M, Martínez N, Hernández V, Del Campo V, Pineda JR, Martínez-Cadilla J, Pereira S, Rodríguez Prada JI. Assessing medication adherence in inflammatory bowel diseases. A comparison between a self-administered scale and a pharmacy refill index. Rev Esp Enferm Dig. 2017 Aug;109(8):542–51. PMID: 28679280. DOI: 10.17235/reed.2017.5137/2017. IF2017: 1.632; Q4. +Pubmed +DOI
• López LC, De Benito Basanta L, Bustelo MS, Corral AB, Lorenzo JRF. Enfermedad de Vogt-Koyanagi-Harada: Una causa rara de uveítis. Acta Pediatr Esp. 2017 Jul;75(7–8):e141–3. IF2017: N/A. Enlace
• Martínez López JA, García Vivar ML, Cáliz R, Freire M, Galindo M, Hernández MV, López Longo FJ, Martínez Taboada V, Pego Reigosa JM, Rubio E, Trujillo E, Vela-Casasempere P. Recommendations for the evaluation and management of patients with rheumatic autoimmune and inflammatory diseases during the reproductive age, pregnancy, postpartum and breastfeeding. Reumatol Clin. 2017 Sep;13(5):264–81. PMID: 27321859. DOI: 10.1016/j.reuma.2016.05.003. IF2017: N/A. +Pubmed +DOI
• Riveros Frutos A, Casas I, Rúa-Figueroa I, López-Longo FJ, Calvo-Alén J, Galindo M, Fernández-Nebro A, Pego-Reigosa JM, Olivé Marqués A, RELESSER Group part of the SS of RSADSG (EASSER). Systemic lupus erythematosus in Spanish males: a study of the Spanish Rheumatology Society Lupus Registry (RELESSER) cohort. Lupus. 2017 Jun;26(7):698–706. PMID: 27799439. DOI: 10.1177/0961203316673728. IF2017: 2.969; Q3. +Pubmed +DOI
• Rúa-Figueroa I, Fernández Castro M, Andreu JL, Sanchez-Piedra C, Martínez-Taboada V, Olivé A, López-Longo J, Rosas J, Galindo M, Calvo-Alén J, Fernández-Nebro A, Alonso F, Rodríguez-Lozano B, Alberto García Vadillo J, Menor R, Narváez FJ, Erausquin C, García-Aparicio Á, Tomero E, Manrique-Arija S, Horcada L, Uriarte E, Gil S, Blanco R, López-González R, Boteanu A, Freire M, Galisteo C, Rodríguez-Gómez M, Díez-Álvarez E, Pego-Reigosa JM, Sjogrenser and Relesser Researchers and EAS-SER Group. Comorbidities in Patients With Primary Sjögren´s Syndrome and Systemic Lupus Erythematosus: A Comparative Registries-Based Study. Arthritis Care Res (Hoboken). 2017 Jan;69(1):38–45. PMID: 27564390. DOI: 10.1002/acr.23015. IF2017: 4.149; Q2. +Pubmed +DOI
• Rúa-Figueroa Í, López-Longo J, Galindo-Izquierdo M, Calvo-Alén J, Del Campo V, Olivé-Marqués A, Pérez-Vicente S, Fernández-Nebro A, Andrés M, Erausquin C, Tomero E, Horcada L, Uriarte E, Freire M, Montilla C, Sánchez-Atrio A, Santos G, Boteanu A, Díez-Álvarez E, Narváez J, Martínez-Taboada V, Silva-Fernández L, Ruiz-Lucea E, Andreu JL, Hernández-Beriain JÁ, Gantes M, Hernández-Cruz B, Pérez-Venegas J, Pecondón-Español Á, Marras C, Ibáñez-Barceló M, Bonilla G, Torrente V, Castellví I, Alegre JJ, Calvet J, Marenco JL, Raya E, Vázquez T, Quevedo V, Muñoz-Fernández S, Rodríguez-Gómez M, Ibáñez J, Pego-Reigosa JM. Incidence, associated factors and clinical impact of severe infections in a large, multicentric cohort of patients with systemic lupus erythematosus. Semin Arthritis Rheum. 2017 Aug;47(1):38–45. PMID: 28259425. DOI: 10.1016/j.semarthrit.2017.01.010. IF2017: 4.365; Q1. +Pubmed +DOI
• Schneider M, Mosca M, Pego-Reigosa J-MM, Gunnarsson I, Maurel F, Garofano A, Perna A, Porcasi R, Devilliers H. Cross-cultural validation of lupus impact tracker in five European clinical practice settings. Rheumatol (United Kingdom). 2017 May;56(5):818–28. PMID: 28204765. DOI: 10.1093/rheumatology/kew492. IF2017: 5.245; Q1. +Pubmed +DOI
• Torrente-Segarra V, Salman Monte TC, Rúa-Figueroa I, Sánchez-Alonso F, López-Longo FJ, Galindo-Izquierdo M, Calvo-Alén J, Olivé-Marqués A, Ibañez-Ruán J, Horcada L, Sánchez-Atrio A, Montilla C, Melero González RB, Díez-Álvarez E, Martinez-Taboada V, Andreu JL, Fernández-Berrizbeitia O, Hernández-Beriain JÁ, Gantes M, Hernández-Cruz B, Pecondón-Español Á, Marras C, Bonilla G, Pego-Reigosa JM, RELESSER Study Group of the Spanish Society of Rheumatology (SER) and the Study Group of Systemic Autoimmune Diseases of the SER (EAS-SER). Juvenile- and adult-onset systemic lupus erythematosus: a comparative study in a large cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER). Clin Exp Rheumatol. 2017 Jun;35(6):1047–55. PMID: 28628467. IF2017: 3.201; Q2. +Pubmed

Artículos Científicos

• Alonso A, Julià A, Vinaixa M, Domènech E, Fernández-Nebro A, Cañete JD, Ferrándiz C, Tornero J, Gisbert JP, Nos P, Casbas AG, Puig L, González-Álvaro I, Pinto-Tasende JA, Blanco R, Rodríguez MA, Beltran A, Correig X, Marsal S, IMID Consortium. Urine metabolome profiling of immune-mediated inflammatory diseases. BMC Med. 2016 Sep;14(1):133. PMID: 27609333. DOI: 10.1186/s12916-016-0681-8. IF2016: 7.901; D1. +Pubmed +DOI
• Blanco-Pérez JJ, Pérez González A, Morano Amado LE, Guerra Vales JL, Vázquez Gallardo R, Salgado Barreira Á, Cruz Carmona MJ, González Barcala FJ. Clinical Significance of Environmental Mycobacteria Isolated From Respiratory Specimens of Patients With and Without Silicosis. Arch Bronconeumol. 2016 Mar;52(3):145–50. PMID: 26304492. DOI: 10.1016/j.arbres.2015.07.007. IF2016: 2.979; Q2. +Pubmed +DOI
• Galindo-Izquierdo M, Rodriguez-Almaraz E, Pego-Reigosa JM, López-Longo FJ, Calvo-Alén J, Olivé A, Fernández-Nebro A, Martinez-Taboada V, Vela-Casasempere P, Freire M, Narváez FJ, Rosas J, Ibáñez-Barceló M, Uriarte E, Tomero E, Zea A, Horcada L, Torrente V, Castellvi I, Calvet J, Menor-Almagro R, Zamorano MAA, Raya E, Díez-Álvarez E, Vázquez-Rodríguez T, García de la Peña P, Movasat A, Andreu JL, Richi P, Marras C, Montilla-Morales C, Hernández-Cruz B, Marenco de la Fuente JL, Gantes M, Úcar E, Alegre-Sancho JJ, Manero J, Ibáñez-Ruán J, Rodríguez-Gómez M, Quevedo V, Hernández-Beriaín J, Silva-Fernández L, Alonso F, Pérez S, Rúa-Figueroa I, RELESSER Group from SS of RSADSG (EASSER). Characterization of Patients With Lupus Nephritis Included in a Large Cohort From the Spanish Society of Rheumatology Registry of Patients With Systemic Lupus Erythematosus (RELESSER). Medicine (Baltimore). 2016 Mar;95(9):e2891. PMID: 26945378. DOI: 10.1097/MD.0000000000002891. IF2016: 1.804; Q2. +Pubmed +DOI
• Pego-Reigosa JM, Lois-Iglesias A, Rúa-Figueroa Í, Galindo M, Calvo-Alén J, de Uña-Álvarez J, Balboa-Barreiro V, Ibáñez Ruan J, Olivé A, Rodríguez-Gómez M, Fernández Nebro A, Andrés M, Erausquin C, Tomero E, Horcada Rubio L, Uriarte Isacelaya E, Freire M, Montilla C, Sánchez-Atrio AI, Santos-Soler G, Zea A, Díez E, Narváez J, Blanco-Alonso R, Silva-Fernández L, Ruiz-Lucea ME, Fernández-Castro M, Hernández-Beriain JÁ, Gantes-Mora M, Hernández-Cruz B, Pérez-Venegas J, Pecondón-Español Á, Marras Fernández-Cid C, Ibáñez-Barcelo M, Bonilla G, Torrente-Segarra V, Castellví I, Alegre JJ, Calvet J, Marenco de la Fuente JL, Raya E, Vázquez-Rodríguez TR, Quevedo-Vila V, Muñoz-Fernández S, Otón T, Rahman A, López-Longo FJ. Relationship between damage clustering and mortality in systemic lupus erythematosus in early and late stages of the disease: cluster analyses in a large cohort from the Spanish Society of Rheumatology Lupus Registry. Rheumatology (Oxford). 2016 Jul;55(7):1243–50. PMID: 27018057. DOI: 10.1093/rheumatol +Pubmed +DOI
• Rodríguez Huerta MD, Trujillo-Martín MM, Rúa-Figueroa Í, Cuellar-Pompa L, Quirós-López R, Serrano-Aguilar P, Spanish SLE CPG Development Group (JM Pego-Reigosa; N Martínez López de Castro). Healthy lifestyle habits for patients with systemic lupus erythematosus: A systemic review. Semin Arthritis Rheum. 2016 Feb;45(4):463–70. PMID: 26522137. DOI: 10.1016/j.semarthrit.2015.09.003. IF2016: 4.498; Q1. +Pubmed +DOI
• Romero-Ventosa EY, Samartín-Ucha M, Martín-Vila A, Martínez-Sánchez ML, Rey Gómez-Serranillos I, Pineiro-Corrales G. Multidisciplinary teams involved: detection of drug-related problems through continuity of care. Farm Hosp. 2016 Nov;40(n06):529–43. PMID: 27894227. DOI: 10.7399/fh.2016.40.6.10506. IF2016: N/A. +Pubmed +DOI
• Schneider M, Mosca M, Pego-Reigosa JM, Hachulla E, Teh L-S, Perna A, Koscielny V, Pike J, Lobosco S, Apolone G. Understanding remission in real-world lupus patients across five European countries. Lupus. 2016 Apr;25(5):505–12. PMID: 26635245. DOI: 10.1177/0961203315619030. IF2016: 2.454; Q3. +Pubmed +DOI
• Torrente-Segarra V, Salman-Monte TC, Rúa-Figueroa Í, Pérez-Vicente S, López-Longo FJ, Galindo-Izquierdo M, Calvo-Alén J, Olivé-Marqués A, Ibañez-Ruán J, Horcada L, Sánchez-Atrio A, Montilla C, Rodríguez-Gómez M, Díez-Álvarez E, Martinez-Taboada V, Andreu JL, Fernández-Berrizbeitia O, Hernández-Beriain JA, Gantes M, Hernández-Cruz B, Pecondón-Español Á, Marras C, Bonilla G, Pego-Reigosa JM, RELESSER Study Group of the Spanish Society of Rheumatology (SER), Study Group of Systemic Autoimmune Diseases of the SER (EAS-SER). Fibromyalgia prevalence and related factors in a large registry of patients with systemic lupus erythematosus. Clin Exp Rheumatol. 2016 Nov;34(2 Suppl 96):S40-7. PMID: 26575317. IF2015: 2.495; Q2. +Pubmed
• Trujillo-Martín MM, Rúa-Figueroa Fernández de Larrinoa I, Ruíz-Irastorza G, Pego-Reigosa JM, Sabio Sánchez JM, Serrano-Aguilar P, en nombre del Grupo Elaborador de la GPC-LES. [Clinical practice guidelines for systemic lupus erythematosus: Recommendations for general clinical management]. Med Clin (Barc). 2016 May;146(9):413.e1-14. PMID: 26975887. DOI: 10.1016/j.medcli.2016.01.013. IF2016: 1.125; Q3. +Pubmed +DOI

Artículos Científicos

• Blanco Pérez JJ, Pérez González A, Guerra Vales JL, Melero Gonzalez R, Pego Reigosa JM. Shrinking Lung in Primary Sjogrën Syndrome Successfully Treated with Rituximab. Arch Bronconeumol. 2015 Sep;51(9):475–6. PMID: 25582545. DOI: 10.1016/j.arbres.2014.11.016. IF2015: 1.771; Q3. +Pubmed +DOI
• Cordero OJ, Varela-Calviño R, López-González T, Calviño-Sampedro C, Viñuela JE, Mouriño C, Hernández-Rodríguez Í, Rodríguez-López M, Aspe de la Iglesia B, Pego-Reigosa JM, Pego JM. CD26 Expression on T Helper Populations and sCD26 Serum Levels in Patients with Rheumatoid Arthritis. PLoS One. 2015 Jul;10(7):e0131992. PMID: 26177310. DOI: 10.1371/journal.pone.0131992. IF2015: 3.057; Q1. +Pubmed +DOI
• Fernández Álvarez R, Martínez González C, Quero Martínez A, Blanco Pérez JJ, Carazo Fernández L, Prieto Fernández A. Guidelines for the diagnosis and monitoring of silicosis. Arch Bronconeumol. 2015 Feb;51(2):86–93. PMID: 25479706. DOI: 10.1016/j.arbres.2014.07.010. IF2015: 1.771; Q3. +Pubmed +DOI
• Fernández-Nebro A, Rúa-Figueroa Í, López-Longo FJ, Galindo-Izquierdo M, Calvo-Alén J, Olivé-Marqués A, Ordóñez-Cañizares C, Martín-Martínez MA, Blanco R, Melero-González R, Ibáñez-Rúan J, Bernal-Vidal JA, Tomero-Muriel E, Uriarte-Isacelaya E, Horcada-Rubio L, Freire-González M, Narváez J, Boteanu AL, Santos-Soler G, Andreu JL, Pego-Reigosa JM, EAS-SER (Systemic Diseases Study Group of Spanish Society of Rheumatology). Cardiovascular Events in Systemic Lupus Erythematosus: A Nationwide Study in Spain From the RELESSER Registry. Medicine (Baltimore). 2015 Jul;94(29):e1183. PMID: 26200625. DOI: 10.1097/MD.0000000000001183. IF2015: 2.133; Q2. +Pubmed +DOI
• Ferraz-Falcao JR, Cadaval-Rodríguez T, Rodríguez-Iglesia RM, del Campo-Pérez VM. [Palliative care needs in the inmobilized population of a Primary Care area in Vigo Spain]. Semergen. 2015 Sep;41(6):305–14. PMID: 25442465. DOI: 10.1016/j.semerg.2014.06.017. IF2015: N/A. +Pubmed +DOI
• García de la Peña Lefebvre P, Nishishinya MB, Pereda CA, Loza E, Sifuentes Giraldo WA, Román Ivorra JA, Carreira P, Rúa-Figueroa I, Pego-Reigosa JM, Muñoz-Fernández S. Efficacy of Raynaud´s phenomenon and digital ulcer pharmacological treatment in systemic sclerosis patients: a systematic literature review. Rheumatol Int. 2015 Sep;35(9):1447–59. PMID: 25824427. DOI: 10.1007/s00296-015-3241-1. IF2015: 1.702; Q3. +Pubmed +DOI
• González Chávez J, Asensi Diez R, Tamayo Bermejo R, Alegre Del Rey EJ, Martínez López de Castro N. [Vedolizumab in Crohn Disease genesis-sefh drug evaluation report]. Farm Hosp. 2015 Sep;39(5):297–308. PMID: 26546942. DOI: 10.7399/fh.2015.39.5.8981. IF2015: N/A. +Pubmed +DOI
• Inês L, Silva C, Galindo M, López-Longo FJ, Terroso G, Romão VC, Rúa-Figueroa I, Santos MJ, Pego-Reigosa JM, Nero P, Cerqueira M, Duarte C, Miranda LC, Bernardes M, Gonçalves MJ, Mouriño-Rodríguez C, Araújo F, Raposo A, Barcelos A, Couto M, Abreu P, Otón-Sanchez T, Macieira C, Ramos F, Branco JC, Silva JAP, Canhão H, Calvo-Alén J, Rheumatic Diseases Registry of the Portuguese Society of Rheumatology, Registry of Systemic Lupus Erythematosus Patients of the Spanish Society of Rheumatology. Classification of Systemic Lupus Erythematosus: Systemic Lupus International Collaborating Clinics Versus American College of Rheumatology Criteria. A Comparative Study of 2,055 Patients From a Real-Life, International Systemic Lupus Erythematosus Cohort. Arthritis Care Res (Hoboken). 2015 Aug;67(8):1180–5. PMID: 25581417. DOI: 10.1002/acr.22539. IF2015: 3.229; Q2. +Pubmed +DOI
• Nishishinya MB, Pereda CA, Muñoz-Fernández S, Pego-Reigosa JM, Rúa-Figueroa I, Andreu J-L, Fernández-Castro M, Rosas J, Loza Santamaría E. Identification of lymphoma predictors in patients with primary Sjögren´s syndrome: a systematic literature review and meta-analysis. Rheumatol Int. 2015 Jan;35(1):17–26. PMID: 24899571. DOI: 10.1007/s00296-014-3051-x. IF2015: 1.702; Q3. +Pubmed +DOI
• Pego-Reigosa JM, Rúa-Figueroa Í, López-Longo FJ, Galindo-Izquierdo M, Calvo-Alén J, Olivé-Marqués A, del Campo V, García-Yébenes MJ, Loza-Santamaría E, Blanco R, Melero-González R, Vela-Casasempere P, Otón-Sánchez T, Tomero-Muriel E, Uriarte-Isacelaya E, Fito-Manteca MC, Freire-González M, Narváez J, Fernández-Nebro A, Zea-Mendoza A, Rosas J, Carlos Rosas J, RELESSER Group from the SS of RSADSG (EASSER). Analysis of disease activity and response to treatment in a large Spanish cohort of patients with systemic lupus erythematosus. Lupus. 2015 Jun;24(7):720–9. PMID: 25516473. DOI: 10.1177/0961203314563818. IF2015: 2.118; Q3. +Pubmed +DOI
• Rúa-Figueroa Í, Richi P, López-Longo FJ, Galindo M, Calvo-Alén J, Olivé-Marqués A, Loza-Santamaría E, Vicente SP, Erausquin C, Tomero E, Horcada L, Uriarte E, Sánchez-Atrio A, Rosas J, Montilla C, Fernández-Nebro A, Rodríguez-Gómez M, Vela P, Blanco R, Freire M, Silva L, Díez-Álvarez E, Ibáñez-Barceló M, Zea A, Narváez J, Martínez-Taboada V, Marenco JL, de Castro MF, Fernández-Berrizbeitia O, Hernández-Beriain JÁ, Gantes M, Hernández-Cruz B, Pérez-Venegas JJ, Pecondón Á, Marras C, Carreira P, Bonilla G, Torrente V, Castellví I, Alegre J, Moreno M, Raya E, de la Peña PG, Vázquez T, Aguirre Á, Quevedo V, Pego-Reigosa JM, EAS-SER (Systemic Diseases Study Group of the Spanish Society of Rheumatology). Comprehensive description of clinical characteristics of a large systemic lupus erythematosus cohort from the Spanish Rheumatology Society Lupus Registry (RELESSER) with emphasis on complete versus incomplete lupus differences. Medicine (Baltimore). 2015 Jan;94(1):e267. PMID: 25569641. DOI: 10.1097/MD.00000000000002 +Pubmed +DOI
• Serrano-Aguilar P, Trujillo-Martin M del M, Pérez de la Rosa A, Cuellar-Pompa L, Saavedra-Medina H, Linertova R, Perestelo-Perez L, Perez-Ramos J, Rivero-Santana A, Spanish SLE CPG Development Group (JM Pego-Reigosa; N Martínez-López de Castro). Patient participation in a Clinical Guideline Development for Systemic Lupus Erythematosus. Patient Educ Couns. 2015 Sep;98(9):1156–63. PMID: 26095343. DOI: 10.1016/j.pec.2015.05.022. IF2015: 2.232; D1. +Pubmed +DOI

Guías de Práctica Clínica

• Grupo de trabajo de la Guía de Práctica Clínica sobre Lupus Eritematoso Sistémico, Alarcón-Torres I, Calvo-Alén J, Cuadrado-Lozano MJ, del Pino Sedeño TM, Frutos-Sanz MÁ, García-Díaz S, Jarque-Ramos I, Martín-Gómez MA, Martínez-Ibáñez MT, Martínez-López de Castro N, Melwani PM, Pazos-Casal P, Pego-Reigosa JM, Rúa-Figueroa Fernández de Larrinoa I, Ruíz-Irastorza G, Serrano-Aguilar P, Sabio Sánchez JM. Guía de Práctica Clínica sobre Lupus Eritematoso Sistémico. Ministerio de Sanidad, Servicios Sociales e Igualdad. Servicio de Evaluación del Servicio Canario de la Salud; 2015. Guías de Práctica Clínica en el SNS.; 2015. NIPO: 680-15-083-4. ISBN: 9788439380894. http://portal.guiasalud.es/GPC/GPC_549_Lupus_SESCS_compl.pdf Enlace

Artículos Científicos

• Alvarez Payero M, Martínez López de Castro N, Ucha Samartín M, Martín Vila A, Vázquez López C, Piñeiro Corrales G. Medication non-adherence as a cause of hospital admissions. Farm Hosp. 2014 Jul;38(4):328–33. PMID: 25137166. DOI: 10.7399/fh.2014.38.4.7660. IF: N/A. +Pubmed +DOI
• Cobo-Ibáñez T, Loza-Santamaría E, Pego-Reigosa JM, Marqués AO, Rúa-Figueroa I, Fernández-Nebro A, Cáliz Cáliz R, López Longo FJ, Muñoz-Fernández S. Efficacy and safety of rituximab in the treatment of non-renal systemic lupus erythematosus: a systematic review. Semin Arthritis Rheum. 2014 Oct;44(2):175–85. PMID: 24830791. DOI: 10.1016/j.semarthrit.2014.04.002. IF: 3.925; Q1. +Pubmed +DOI
• Fernández-Nebro A, Marenco JL, López-Longo F, Galindo M, Hernández-Cruz BE, Narváez J, Rúa-Figueroa I, Raya-Alvarez E, Zea A, Freire M, Sánchez-Atrio AI, García-Vicuña R, Pego-Reigosa JM, Manrique-Arija S, Nieves-Martín L, Carreño L. The effects of rituximab on the lipid profile of patients with active systemic lupus erythematosus: results from a nationwide cohort in Spain (LESIMAB). Lupus. 2014 Sep;23(10):1014–22. PMID: 24833667. DOI: 10.1177/0961203314534909. IF: 2.197; Q3. +Pubmed +DOI
• Rúa-Figueroa I, López-Longo FJ, Calvo-Alén J, Galindo-Izquierdo M, Loza E, García de Yebenes MJ, Pego-Reigosa JM. National registry of patients with systemic lupus erythematosus of the Spanish Society of Rheumatology: objectives and methodology. Reumatol Clin. 2014 Jan;10(1):17–24. PMID: 23871155. DOI: 10.1016/j.reuma.2013.04.013. IF: N/A. +Pubmed +DOI
• Silva-Fernández L, Loza E, Martínez-Taboada VM, Blanco R, Rúa-Figueroa I, Pego-Reigosa JM, Muñoz-Fernández S, Systemic Autoimmune Diseases Study Group of the Spanish Society for Rheumatology (EAS-SER). Biological therapy for systemic vasculitis: a systematic review. Semin Arthritis Rheum. 2014 Feb;43(4):542–57. PMID: 23978781. DOI: 10.1016/j.semarthrit.2013.07.010. IF: 3.925; Q1. +Pubmed +DOI
• Tejera Segura B, Holgado S, Mateo L, Pego-Reigosa JM, Carnicero Iglesias M, Olivé A. Síndrome de Löfgren: estudio de 80 casos. Med Clin (Barc). 2014 Aug;143(4):166–9. PMID: 24855899. DOI: 10.1016/j.medcli.2014.02.029. IF: 1.417; Q2. +Pubmed +DOI
• Ucha Sanmartin M, Martín Vila A, López Vidal C, Caaamaño Barreiro M, Piñeiro Corrales G. [Prevention of medication errors in healthcare transition of patients treated with apomorphine]. Farm Hosp. 2014 May;38(3):227–30. PMID: 24951908. DOI: 10.7399/fh.2014.38.3.7430. IF: N/A. +Pubmed +DOI